NanoLogix, Inc., (NNLX), a Nanobiotechnology company (formerly "Infectech"), has announced that "it has filed a provisional patent application for its proprietary method of synergistically combining a bacteria-based hydrogen production method with excess industrial heat. NanoLogix recently announced that preliminary data and results of a study which confirms laboratory proof-of-concept measurements have shown it possible to generate hydrogen in high yields. In this study, the bioreactor produced biogas consisting of 50% hydrogen by volume, without any trace of methane
".The announcement mentions "Clostridia", which presumably could be the type of bacteria involved. According to the Merck manual online edition, "Clostridia are toxin-producing anaerobic bacteria that cause a number of serious diseases, including tetanus, botulism, and tissue infections. Clostridia normally inhabit the human intestinal tract, soil, and decaying vegetation. All species of clostridia produce toxins. Some clostridial diseases, such as botulism and the various diarrheal illnesses, result solely from the toxin without any bacterial invasion of tissue. In other clostridial diseases, such as tetanus and clostridial wound infections, there is both tissue invasion and toxin production
In an ideal outcome, Nanologix would be able to utilize a relatively benign species from this group of anaerobes to produce hydrogen from food scraps and industrial waste heat, such as from electrical utilities. That would be one good nanobiotreehuggin' burp for the future of mankind.
Who would have thought that a biomedical firm in the small Pennsylvania City of Sharon (an hour from Pittsburg) would come up with a way to fuel cars using a bacterium best known for food poisoning. Wild Explanation: -- Pennsylvania translates to "Penn's Woods" and nano-tech types can be Tree Huggers too.